Absolute quantification of podocin, a potential biomarker of glomerular injury in human urine, by liquid chromatography-multiple reaction monitoring cubed mass spectrometry

Abstract : Glomeruli play a major role in the kidney function since they are involved in primary urine formation. It is then crucial to dispose of methods to monitor glomerular injury, especially in drug development. In this context, quantification of podocin could be of great interest since it is a protein exclusively present in highly specialized glomerulus cells called podocytes. Immunoassays are the most commonly used approach for protein assays. However, they rely on the availability of specific antibodies. When such antibodies are not available, liquid chromatography tandem mass spectrometry (LC-MS/MS), in selected reaction monitoring (SRM) or in multiple reaction monitoring cubed (MRM(3)) mode, has been demonstrated as a powerful alternative technique, and can be applied to multiple protein quantification. This paper describes the development of a quantification method of human podocin in urine by LC-MS/MS in MRM(3) mode. Inter assay precision and accuracy ranged from 7 to 20% and from 105 to 112% respectively and the lower limit of quantification (LLOQ) was 0.39ng/mL from only 1mL of urine which is compatible for endogenous level of podocin determination.
Type de document :
Article dans une revue
Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2014, 94, pp.84-91. 〈10.1016/j.jpba.2014.01.019〉
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-00954969
Contributeur : Agnès Bussy <>
Soumis le : lundi 3 mars 2014 - 16:58:49
Dernière modification le : jeudi 8 février 2018 - 11:10:27

Identifiants

Collections

Citation

Romain Simon, Jérôme Lemoine, Catherine Fonbonne, Aurore Jaffuel, Jean-François Léonard, et al.. Absolute quantification of podocin, a potential biomarker of glomerular injury in human urine, by liquid chromatography-multiple reaction monitoring cubed mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2014, 94, pp.84-91. 〈10.1016/j.jpba.2014.01.019〉. 〈hal-00954969〉

Partager

Métriques

Consultations de la notice

120